PsoriasisUpdated 9 days ago
Sulforaphane has been found to improve psoriatic symptoms. It supports cellular health and helps the body respond to oxidative stress and inflammation—key factors in psoriasis flare-ups. Its mechanisms of action include:
Enhanced Antioxidant Defenses
Reduced Inflammation + Suppression of Pro-Inflammatory Enzymes
How it Works:
Enhanced Antioxidant Defenses
Sulforaphane activates the nuclear factor erythroid 2–related factor 2 (NRF2) pathway, leading to the upregulation of antioxidant enzymes. This enhances the skin's defense against oxidative stress, which is implicated in inflammatory conditions like psoriasis.
This study demonstrated sulforaphane’s ability to alleviate psoriasis in murine models by enhancing antioxidant defenses through KEAP1-NRF2 pathway activation, resulting in reduced inflammatory signaling, decreased keratinocyte differentiation, and reduced cutaneous inflammation.
Reduced Inflammation + Suppression of Pro-Inflammatory Enzymes
Sulforaphane exerts anti-psoriatic effects by inhibiting the STAT3 and NF-κB pathways, which are central to psoriatic inflammation, resulting in downregulation of pro-inflammatory cytokines such as IL-1β, IL-6, and CCL2 in both in vivo and in vitro models.
Sulforaphane ameliorates psoriasis-like skin inflammation in murine models by reducing Th1 and Th17 effector T cells—key drivers of psoriatic inflammation—and by upregulating antioxidant gene expression to attenuate oxidative stress and cutaneous inflammation.
The results of this study showed that these immunomodulatory and antioxidant effects result in improved clinical and histopathological features of psoriasis, including lower PASI scores, reduced acanthosis, and diminished dermal inflammatory cell infiltration.